home / stock / kkr / kkr news


KKR News and Press, KKR & Co. Inc. Class A

Stock Information

Company Name: KKR & Co. Inc. Class A
Stock Symbol: KKR
Market: NYSE
Website: kkr.com

Menu

KKR KKR Quote KKR Short KKR News KKR Articles KKR Message Board
Get KKR Alerts

News, Short Squeeze, Breakout and More Instantly...

KKR - Axel Springer buys the UK's Telegraph newspaper for $770M, plans U.S. expansion

2026-03-06 10:57:33 ET More on KKR & Co. KKR & Co. Inc. (KKR) Presents at Bank of America Financial Services Conference 2026 Transcript KKR & Co. Inc. (KKR) Presents at UBS Financial Services Conference 2026 Transcript KKR & Co. Inc. 2025 Q4 - Results...

KKR - 2 Retirement Yield Picks That Give You The Right To Win

2026-03-05 16:34:30 ET In management consulting, which is my background, there is a common question that consultants and corporate leaders try to address together before embarking on new capital allocation: Does your strategy give you the right to win? Read the full article on...

KKR - South Korea Private Equity Deal Activity Falls In 2025

2026-03-05 08:33:00 ET Global private equity and venture capital deal value in South Korea totaled $8.58 billion, down 38.8% from the prior year and the lowest annual figure since at least 2020.... Read the full article on Seeking Alpha For further details see: South Kor...

KKR - Stock Market Today, March 3: Blue Owl Falls Amid Rising Private Credit Redemption Activity

2026-03-03 17:20:31 ET Blue Owl Capital (NYSE:OWL) , a private credit and permanent capital provider, closed Tuesday at $10.27, down 3.89%. Shares slid after fresh reports on liquidity strains, withdrawal limits, and sector-wide redemption pressure in private credit, and investors a...

KKR - Capital Group launches fund that invests in, alongside KKR's assets

2026-03-03 12:22:33 ET More on KKR & Co. KKR & Co. Inc. (KKR) Presents at Bank of America Financial Services Conference 2026 Transcript KKR & Co. Inc. (KKR) Presents at UBS Financial Services Conference 2026 Transcript KKR & Co. Inc. 2025 Q4 - Results...

KKR - Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst(TM) (bumetanide nasal spray)

– Enbumyst ™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to Leverage Esperion’s Established Cardiovascular Commercial Infrastructure, Synergistically Expand Product Portfolio and Accelerate Doub...

KKR - Blackstone: Don't Let Sentiment Obscure The Fundamentals (Rating Upgrade)

2026-03-03 00:49:19 ET When I first wrote about Blackstone ( BX ) in January, it was trading near $160, and at that price I argued that even though the stock was fairly valued according to my estimates, there was still upside because of the quality of the underlying business.... ...

KKR - CDT Insider Sentiment February 2026: Antifragile

2026-03-02 13:05:00 ET The End of a Winning Streak. After 9 months of unrelenting gains, the market did the unthinkable in February - it declined in value. For the month of February, the S&P 500 TR Index logged a modest -.75% loss and intra-month volatility t...

KKR - Jefferies updates its AI Risk Basket

2026-03-01 13:50:45 ET More on Direxion Daily AI and Big Data Bear 2X Shares ETF Seeking Alpha’s Quant Rating on Direxion Daily AI and Big Data Bear 2X Shares ETF Dividend scorecard for Direxion Daily AI and Big Data Bear 2X Shares ETF Read the full article ...

KKR - A Private Credit Crisis Is Possibly Brewing

2026-03-01 06:27:09 ET The problems that have cropped up in the burgeoning private credit markets remind me of a famous scene in ' Monty Python & The Holy Grail.' This is the long scene that begins with Sir Lancelot charging a castle gate manned by two nonchalant guards. Most of...

Next 10